Showing results (2111-2120 of 11,033) with videos related to
Sort By:
Pageof 1,104
Journal of the National Cancer Institute|July 24, 2013
Advanced prostate cancer risk in relation to toenail selenium levelsMilan S Geybels, Bas A J Verhage, Frederik J van Schooten, et al.Journal of the National Cancer Institute|January 11, 2012
Estrogen metabolism and risk of breast cancer in postmenopausal womenBarbara J Fuhrman, Catherine Schairer, Mitchell H Gail, et al.Journal of the National Cancer Institute|August 15, 1990
Recombinant interleukin-2 and adoptive immunotherapy alternated with dacarbazine therapy in melanoma: a National Biotherapy Study Group trialR O Dillman, R K Oldham, N M Barth, et al.Journal of the National Cancer Institute|October 6, 2011
Development and validation of a prognostic nomogram for terminally ill cancer patientsJaime Feliu, Ana María Jiménez-Gordo, Rosario Madero, et al.Journal of the National Cancer Institute|October 29, 2011
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancersChristos Hatzis, Hongxia Sun, Hui Yao, et al.Journal of the National Cancer Institute|October 26, 2011
The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinomaJing Ai, Qingjuan Tang, Yanlin Wu, et al.Journal of the National Cancer Institute|October 18, 1989
Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatinR Goel, S M Cleary, C Horton, et al.Journal of the National Cancer Institute|December 6, 1989
Smoking, air pollution, and the high rates of lung cancer in Shenyang, ChinaZ Y Xu, W J Blot, H P Xiao, et al.Journal of the National Cancer Institute|December 7, 2014
Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testingCarolina Porras, Allan Hildesheim, Paula González, et al.Journal of the National Cancer Institute|March 6, 2016
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United StatesWilliam V Padula, Richard A Larson, Stacie B Dusetzina, et al.Pageof 1,104